IOS Parameters and PAP Titration Pressure in Obstructive Sleep Apnea

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorMustafa Kemal University

About this trial

This prospective observational study aims to investigate whether impulse oscillometry (IOS)-a non-invasive lung function test-can help predict the specific pressure settings needed for positive airway pressure (PAP) therapy in patients with obstructive sleep apnea (OSA).

Currently, finding the optimal therapeutic pressure for OSA patients typically requires a titration process during sleep. This study explores if IOS parameters, which measure airway resistance and elasticity through small pressure oscillations during normal breathing, correlate with the final titration pressures (CPAP, EPAP, IPAP, and ΔP) determined by polysomnography.

Adult patients diagnosed with moderate-to-severe OSA (Apnea-Hypopnea Index ≥ 15) will undergo standard diagnostic sleep testing followed by IOS testing using the Vyaire Vyntus BodyBox® system. The researchers will evaluate whether these respiratory measurements can accurately predict required airway pressures and if they can help clinicians distinguish between patients who need Continuous Positive Airway Pressure (CPAP) versus Bilevel Positive Airway Pressure (BPAP) therapy.

Eligibility criteria

Qualifiers

Adults aged 18 to 80 years

Diagnosed with obstructive sleep apnea (OSA) by overnight polysomnography (PSG)

Apnea-hypopnea index (AHI) ≥ 15

Undergoing positive airway pressure (PAP) titration (CPAP or BPAP)

Disqualifiers

Central sleep apnea

Neuromuscular disease or restrictive lung disease

Recent upper airway infection (< 2 weeks)

Incomplete PSG or IOS data

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

92 Participants
are grouped into 1 trial group

Sponsors and collaborators